35.43
+2.25(+6.78%)
Currency In USD
| Previous Close | 33.18 |
| Open | 33.44 |
| Day High | 35.96 |
| Day Low | 33.16 |
| 52-Week High | 98.38 |
| 52-Week Low | 27.8 |
| Volume | 2.33M |
| Average Volume | 1.32M |
| Market Cap | 1.98B |
| PE | -23.16 |
| EPS | -1.53 |
| Moving Average 50 Days | 33.2 |
| Moving Average 200 Days | 48.39 |
| Change | 2.25 |
If you invested $1000 in PROCEPT BioRobotics Corporation (PRCT) since IPO date, it would be worth $844.78 as of December 04, 2025 at a share price of $35.43. Whereas If you bought $1000 worth of PROCEPT BioRobotics Corporation (PRCT) shares 3 years ago, it would be worth $777.31 as of December 04, 2025 at a share price of $35.43.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
PROCEPT BioRobotics® to Present at Upcoming 37th Annual Piper Sandler Healthcare Conference on December 2, 2025
GlobeNewswire Inc.
Nov 20, 2025 9:03 PM GMT
SAN JOSE, Calif., Nov. 20, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced that members of
PROCEPT BioRobotics® to Report Third Quarter 2025 Financial Results on November 4, 2025
GlobeNewswire Inc.
Oct 15, 2025 8:03 PM GMT
SAN JOSE, Calif., Oct. 15, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced it
PROCEPT BioRobotics® President and CEO Dr. Reza Zadno to Retire, Company Appoints Larry L. Wood as New President and CEO
GlobeNewswire Inc.
Jul 24, 2025 10:00 PM GMT
Larry L. Wood to join PROCEPT BioRobotics effective September 2, 2025Company confirms strong underlying business trends and pre-announces 2Q25 revenue of approximately $79.2 million, representing annual growth of 48% SAN JOSE, Calif., July 24, 2025